Milan Lerch

Milan Lerch

Auto-generated profile, based on publicly available information

Milan Lerch

Department of Surgery, Silesian Hospital in Opava, Opava, Czech Republic

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
PDF file
MLMilan Lerch
Milan Lerch
DSDemet Sengul
Demet Sengul
ISIlker Sengul
Ilker Sengul
MPMatúš Peteja
Matúš Peteja
LPLenka Přibylová
Lenka Přibylová
VJVladimír Janout
Vladimír Janout
This study purposed to evaluate preoperative two tumor markers, namely, carcinoembryonic antigen and carbohydrate antigen (CA)19-9, in colorectal cancer for anatomotopographic location with disease stage and to assess their utility for diagnostic staging purposes.

4 April 2022 in European Journal of Medical Research
Verified
Journal Article
Open access
PDF file
JŽJan Žatecký
Jan Žatecký
MPMatúš Peteja
Matúš Peteja
WGWladyslaw Gawel
Wladyslaw Gawel
MLMilan Lerch
Milan Lerch
Background: This paper describes a unique case—the first case of multiple fractures of the thoracic vertebrae caused by a low-voltage electric shock. Case presentation: A 22-year-old male patient was diagnosed with compression fractures of Th2–Th6 caused by a muscle spasm resulting from an electric shock. The patient was treated conservatively using a cervico-thoracic support corset. After rehabilitation, the patient has regained his physiological movement of the spine without any back pain. Conclusions: Albeit vertebral fractures caused by electric shock injury are extremely rare, clinicians should always keep in mind this diagnosis, especially when clinical symptoms such as pain and limitation of movement are present.

1 March 2023 in Turkish Journal of Surgery
Verified
Journal Article
Open access
PDF file
JŽJan Žatecký
Jan Žatecký
OCOldřich Coufal
Oldřich Coufal
MHMiloš Holánek
Miloš Holánek
OKOtakar Kubala
Otakar Kubala
MKMarkéta Kepičová
Markéta Kepičová
MPMatúš Peteja
Matúš Peteja
Objective: The purpose of the study was to investigate the oncological sufficiency of level I axillary dissection for adequate histological nodal staging (ypN) in patients with breast cancer and tumor-involved sentinel lymph node (SLN) after neoadjuvant chemotherapy (NAC). Material and Methods: A prospective multicentre pilot study took place from 01.01.2018 to 30.11.2020 in three mammary centres in the Czech Republic in patients with breast cancer after NAC (NCT03556397). Patients in the cohort with positive histological frozen section of SLN were indicated to separate axillary dissection of levels I and II. Results: Sixty-one patients with breast cancer after NAC were included in the study according to inclusion and exclusion criteria. Twelve patients with breast cancer and tumour involved SLN after NAC were further included in the analysis. Two (16.7%) patients had positive non-sentinel lymph nodes in level I only, one (8.3%) patient had positive lymph nodes in level II only, and seven (58.3%) patients had positive lymph nodes in both levels. Level I axillary dissection in a patient with tumour involved SLN after NAC would have resulted in understaging in five (41.7%) patients, mostly ypN1 instead of ypN2. Conclusion: According to our pilot result, level I axillary dissection is not sufficient in terms of adequate histological nodal staging in breast cancer patients after NAC, and level II axillary dissection should not be omitted.